Mana.bio

AI-based Programmable Drug Delivery

Health Tech & Life Sciences
Active
Seed Haifa, Israel Founded 2021
Last updated 2026-06-18
Total raised
$24.5M
Last: 2023-10
Stage
Seed
Founded
2021
Headcount
19
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

Mana.bio specializes in AI-based drug-delivery solutions, with a focus on gene therapy. The companys technology integrates machine learning and nanotechnology for the development of drug-delivery systems.

Mana.bio has created a platform for lipid nanoparticle development for oligonucleotide therapies, including mRNA-based therapeutics, vaccines, and gene therapy.

The technology is powered by an integration of machine learning and nanotechnology in order to identify formulations of lipid nanoparticles drug delivery systems.

Funding history · 2 rounds · $24.5M total

Q&A

What is Mana.bio's primary focus?
Mana.bio specializes in AI-based drug-delivery solutions, with a focus on gene therapy.
When was Mana.bio founded?
Mana.bio was founded in October 2021.
What is Mana.bio's total funding to date?
Mana.bio has raised a total of $24,500,000 USD.
When was Mana.bio's most recent funding round and how much was raised?
Mana.bio's most recent funding round was in October 2023, raising $19,500,000 USD.
Which investors participated in Mana.bio's October 2023 funding round?
The October 2023 funding round included investors such as LionBird and Technion Research &.
Who are the co-founders of Mana.bio?
The co-founders of Mana.bio are Yogev Debbi (Co-founder & CEO) and Roy Nevo (Co-founder & CTO).
What technology does Mana.bio utilize for its drug delivery systems?
Mana.bio integrates machine learning and nanotechnology to identify formulations of lipid nanoparticles for drug delivery systems.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2B

Highlights

Verified

Tags

pharmaceuticalsmachine-learningnanotechnologyartificial-intelligencegeneticsdrug-deliverycell-therapytherapeutics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitemana.bio/
LinkedInlinkedin.com/company/76563098

Identifiers & details

Founded2021-10
Employees (exact)19
OfficesTel Aviv-Yafo

Radar intelligence

Patents

EPO4

Web history (Wayback)

Domainmana.bio

Certificate / subdomain footprint

Subdomains10